Skip to main content
Watch Insiders
RGNXHealthcare

Regenxbio Inc (RGNX) Insider Trading

In the last 90 days, 1 Regenxbio Inc (RGNX) insider reported 1 open-market purchase totaling $949,386 and no sales. The most recent open-market purchase was reported on Aug 27, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$949,386
Corporate buyers
1
Latest transaction
Aug 27, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 27, 2026Gregory Austin CiongoliDirectorOpen Market Purchase102,603$9.25$949,386
Jul 2, 2026Steve PakolaChief Medical OfficerSale2,161$13.64$29,476
Jul 1, 2026Steve PakolaChief Medical OfficerSale56,333$12.23$688,755
May 11, 2026Steve PakolaChief Medical OfficerSale15,309$11.02$168,705

Common questions

RGNX insider trading FAQ

Are RGNX insiders buying or selling?
Over the last 90 days, RGNX insiders were net buyers, reporting $949,386 of open-market purchases and $0.00 of sales.
When was the last RGNX insider purchase?
The most recent open-market purchase of Regenxbio Inc stock by an insider was reported on Aug 27, 2026, one of 1 purchase in the last 90 days.
Where does RGNX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Regenxbio Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.